.

Exelixis reported $304.52M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Akebia Therapeutics AKBA:US $ 233.68M 20.23M
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Bayer BAYN:GR € 33643M 2624M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Cytokinetics CYTK:US $ 66.84M 0M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Esperion Therapeutics ESPR:US $ 82.28M 3.19M
Exelixis EXEL:US $ 304.52M 15.44M
Genmab GEN:DC DK 1944M 605M
Glaxosmithkline GSK:US $ 37835M 13557M
Immunogen IMGN:US $ 87.07M 2.95M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Macrogenics MGNX:US $ 50.88M 16.22M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Moderna Inc MRNA:US 6.81B 2.43B
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Takeda 4502:JP Y 2166942M 21212M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Xencor XNCR:US $ 75.04M 14.1M
YTE INCY:US $ 926.67M 40.51M